Liu XL - Search Results

1

Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway.

Li JL, Liu XL, Guo SF, Yang Y, Zhu YL, Li JZ. Li JL, et al. Among authors: liu xl. Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9238-9250. doi: 10.26355/eurrev_201911_19416. Eur Rev Med Pharmacol Sci. 2019. PMID: 31773675 Free article.

2

DDA1 is induced by NR2F6 in ovarian cancer and predicts poor survival outcome.

Liu J, Li T, Liu XL. Liu J, et al. Among authors: liu xl. Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1206-1213. Eur Rev Med Pharmacol Sci. 2017. PMID: 28387912 Free article.

3

MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.

Yang H, Wei YN, Zhou J, Hao TT, Liu XL. Yang H, et al. Among authors: liu xl. Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3200-3206. Eur Rev Med Pharmacol Sci. 2017. PMID: 28770965 Free article.

4

Has-MiR-196a-2 is up-regulated and acts as an independent unfavorable prognostic factor in thyroid carcinoma.

Fu YT, Zhang DQ, Zhou L, Li SJ, Sun H, Liu XL, Zheng HB. Fu YT, et al. Among authors: liu xl. Eur Rev Med Pharmacol Sci. 2018 May;22(9):2707-2714. doi: 10.26355/eurrev_201805_14967. Eur Rev Med Pharmacol Sci. 2018. PMID: 29771422 Free article.

5

MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.

Zhang L, Liu XL, Yuan Z, Cui J, Zhang H. Zhang L, et al. Among authors: liu xl. Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4663-4672. doi: 10.26355/eurrev_201906_18046. Eur Rev Med Pharmacol Sci. 2019. PMID: 31210292 Free article.

6

PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2.

Liu XL, Liu HM, Han N, Li FH, Sun F, Fan DM, Xu Q. Liu XL, et al. Among authors: liu hm. Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8239-8248. doi: 10.26355/eurrev_201910_19133. Eur Rev Med Pharmacol Sci. 2019. PMID: 31646554 Free article.

7

Long non-coding RNA TTN-AS1 promotes the metastasis in breast cancer by epigenetically activating DGCR8.

Qiu P, Dou Y, Ma LZ, Tang XX, Liu XL, Chen JW. Qiu P, et al. Among authors: liu xl. Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10835-10841. doi: 10.26355/eurrev_201912_19787. Eur Rev Med Pharmacol Sci. 2019. Retraction in: Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7559. doi: 10.26355/eurrev_202007_22212 PMID: 31858552 Free article. Retracted.

8

Visfatin relieves myocardial ischemia-reperfusion injury through activation of PI3K/Akt/HSP70 signaling axis.

Xin BR, Li P, Liu XL, Zhang XF. Xin BR, et al. Among authors: liu xl. Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10779-10789. doi: 10.26355/eurrev_202010_23438. Eur Rev Med Pharmacol Sci. 2020. PMID: 33155238 Free article.

9

MDM4 is targeted by miR-449b-5p to promote the proliferation of endometrial carcinoma.

Zhao J, Dong X, Tao SJ, Liu XL, Li Z, Liu JM, Chen Y. Zhao J, et al. Among authors: liu jm, liu xl. Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11528-11535. doi: 10.26355/eurrev_202011_23794. Eur Rev Med Pharmacol Sci. 2020. PMID: 33275219 Free article.

10

Inducible nitric oxide inhibitor enhances the anti-tumor effect of cisplatin on CNE-2 cells by inducing cell apoptosis.

Zhang HX, Deng C, Liu OS, Liu XL, Wu F, Wang JJ, Feng YQ, Hu CH, Tang ZG. Zhang HX, et al. Among authors: liu os, liu xl. Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2789-97. Eur Rev Med Pharmacol Sci. 2014. PMID: 25339471 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,267 results

Search Page

Filters